| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics | Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | 2.97M | $162M | $54.63 | Sep 2, 2025 | Indirect |
| MoonLake Immunotherapeutics | Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | 203K | $11.1M | $54.63 | Sep 2, 2025 | Direct |
| MoonLake Immunotherapeutics | Chief Scientific Officer | Stock Option (Right to Buy) | 139K | Feb 27, 2025 | Direct | ||
| MoonLake Immunotherapeutics | Chief Scientific Officer | Class C ordinary shares, par value $0.0001 per share | 35.4K | Sep 2, 2025 | Direct | ||
| MoonLake Immunotherapeutics | Chief Scientific Officer | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1.05K | Jan 20, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | Sep 2, 2025 | 3 | $0 | 4 | Sep 4, 2025 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Feb 27, 2025 | 1 | $0 | 4 | Mar 3, 2025 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Jan 20, 2025 | 3 | $0 | 4 | Jan 22, 2025 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Feb 27, 2024 | 4 | -$6.54M | 4 | Feb 29, 2024 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Feb 20, 2024 | 4 | -$1.21M | 4 | Feb 22, 2024 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Feb 14, 2024 | 6 | -$3.65M | 4 | Feb 16, 2024 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Oct 1, 2023 | 6 | $0 | 4 | Oct 3, 2023 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Apr 5, 2023 | 6 | $0 | 4 | Apr 7, 2023 | Chief Scientific Officer |
| MLTX | MoonLake Immunotherapeutics | Apr 5, 2022 | 0 | $0 | 3 | Apr 15, 2022 | Chief Scientific Officer |